AdoRx Therapeutics

KyDo Therapeutics

This company develops covalent-allosteric small molecule inhibitors for the treatment of challenging cancer variants within the oncology sector.

ARase Therapeutics

This company develops small molecule drugs targeting ADP-ribose hydrolases for patients with various forms of cancer.

THERAtRAME

The company develops small molecule inhibitors targeting tRNA epitranscriptomics to treat resistant and immune-refractory cancers for patients with limited therapeutic options.

Adaptam Therapeutics

Adaptam Therapeutics develops antibody-based therapies for solid tumours to treat oncology patients by targeting immunosuppressive myeloid cells.

Adcytherix

This biopharmaceutical company develops novel antibody-drug conjugates to treat various forms of cancer for patients with high unmet clinical needs.

Advesya

This biotech company develops immunotherapies and antibody-drug conjugates targeting IL-1RAP for patients with cancer and autoimmune diseases.

Taveren Therapeutics

The company develops oncology drug candidates that reactivate natural tumour suppressors for pharmaceutical partners and cancer patients.

Ambagon Therapeutics

The company develops small-molecule stabilisers to modulate protein interactions for the treatment of cancer and other serious diseases.